Janney Montgomery Scott LLC Has $993,000 Position in Sanara MedTech Inc. (NASDAQ:SMTI)

Janney Montgomery Scott LLC lessened its holdings in Sanara MedTech Inc. (NASDAQ:SMTI) by 41.5% in the 3rd quarter, Holdings Channel reports. The firm owned 32,846 shares of the company’s stock after selling 23,343 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Sanara MedTech were worth $993,000 as of its most recent SEC filing.

Separately, Vanguard Group Inc. raised its holdings in Sanara MedTech by 3.1% in the 1st quarter. Vanguard Group Inc. now owns 144,394 shares of the company’s stock worth $5,343,000 after acquiring an additional 4,348 shares during the period. Institutional investors and hedge funds own 8.10% of the company’s stock.

Sanara MedTech Stock Performance

Shares of SMTI opened at $34.65 on Friday. The company has a market capitalization of $303.19 million, a PE ratio of -35.35 and a beta of 1.55. Sanara MedTech Inc. has a one year low of $26.00 and a one year high of $43.25. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.23 and a quick ratio of 1.49. The company’s fifty day moving average price is $32.43 and its 200 day moving average price is $31.30.

Sanara MedTech Profile

Sanara MedTech Inc, a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers.